0001209191-22-015795.txt : 20220303
0001209191-22-015795.hdr.sgml : 20220303
20220303180502
ACCESSION NUMBER: 0001209191-22-015795
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Cecilia
CENTRAL INDEX KEY: 0001840056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38707
FILM NUMBER: 22710820
MAIL ADDRESS:
STREET 1: C/O LOGICBIO THERAPEUTICS, INC.
STREET 2: 65 HAYDEN AVENUE, 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664106
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 471514975
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-245-0399
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-01
0
0001664106
LogicBio Therapeutics, Inc.
LOGC
0001840056
Jones Cecilia
C/O LOGICBIO THERAPEUTICS, INC.
65 HAYDEN AVE, FLOOR 2
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
0.70
2022-03-01
4
A
0
112000
0.00
A
2032-03-01
Common Stock
112000
112000
D
The options were granted by LogicBio Therapeutics, Inc. (the "Company") pursuant to its 2018 Equity Incentive Plan.
The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Company on each vesting date.
/s/ Andrea Paul, as Attorney-in-Fact
2022-03-03